Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Intellia Therapeutics (NTLA) Shares Issued: 2017-2025

Historic Shares Issued for Intellia Therapeutics (NTLA) over the last 8 years, with Jun 2025 value amounting to $1.2 million.

  • Intellia Therapeutics' Shares Issued rose 4.92% to $1.2 million in Q2 2025 from the same period last year, while for Jun 2025 it was $5.1 million, marking a year-over-year decrease of 33.10%. This contributed to the annual value of $5.9 million for FY2024, which is 11.17% down from last year.
  • According to the latest figures from Q2 2025, Intellia Therapeutics' Shares Issued is $1.2 million, which was up 20.10% from $1.0 million recorded in Q4 2024.
  • Intellia Therapeutics' 5-year Shares Issued high stood at $1.8 billion for Q3 2021, and its period low was -$386.7 million during Q2 2022.
  • In the last 3 years, Intellia Therapeutics' Shares Issued had a median value of $1.2 million in 2025 and averaged $1.5 million.
  • Per our database at Business Quant, Intellia Therapeutics' Shares Issued soared by 13,368.75% in 2021 and then tumbled by 133.17% in 2022.
  • Quarterly analysis of 5 years shows Intellia Therapeutics' Shares Issued stood at $1.8 billion in 2021, then tumbled by 99.96% to $386.0 million in 2022, then crashed by 99.74% to $995,000 in 2023, then grew by 3.52% to $1.0 million in 2024, then climbed by 4.92% to $1.2 million in 2025.
  • Its Shares Issued was $1.2 million in Q2 2025, compared to $1.0 million in Q4 2024 and $1.7 million in Q3 2024.